2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 17.038 | 21.582 | 19.668 | 18.995 | 17.772 | 15.080 | 8.979 | 12.402 | 14.105 | 13.483 |
Total Income - EUR | 17.038 | 21.582 | 19.668 | 18.995 | 17.772 | 15.080 | 8.979 | 12.402 | 14.105 | 13.483 |
Total Expenses - EUR | 20.882 | 23.848 | 21.947 | 19.284 | 16.999 | 16.860 | 11.014 | 13.546 | 13.601 | 12.683 |
Gross Profit/Loss - EUR | -3.845 | -2.267 | -2.280 | -289 | 772 | -1.780 | -2.036 | -1.144 | 504 | 800 |
Net Profit/Loss - EUR | -4.356 | -2.914 | -2.774 | -859 | 239 | -2.233 | -2.295 | -1.144 | 316 | 672 |
Employees | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Viriomeda S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Assets | 5.604 | 6.321 | 6.750 | 8.409 | 9.216 | 6.863 | 5.144 | 3.883 | 4.959 | 5.098 |
Inventories | 5.582 | 6.268 | 6.002 | 8.124 | 8.383 | 6.069 | 4.535 | 2.508 | 3.631 | 3.448 |
Receivables | 0 | 0 | 0 | 0 | 412 | 0 | 56 | 0 | 2 | 0 |
Cash | 23 | 54 | 748 | 285 | 422 | 794 | 553 | 1.375 | 1.326 | 1.650 |
Shareholders Funds | -48.166 | -51.482 | -53.731 | -53.229 | -52.013 | -53.238 | -54.524 | -54.459 | -54.313 | -53.477 |
Social Capital | 47 | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 |
Debts | 53.770 | 57.803 | 60.481 | 61.638 | 61.229 | 60.101 | 59.669 | 58.342 | 59.272 | 58.575 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4771 - 4771" | |||||||||
CAEN Financial Year |
4771
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Viriomeda S.r.l.